Back
Taysha Gene Therapies, Inc. Stock Predictions
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
60
TSHA
Taysha Gene Therapies, Inc.
Last Price:
$5.48
Seasonality Move:
-16.58%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiTaysha Gene Therapies, Inc. Stock Forecast
-
Over the next 52 weeks, Taysha Gene Therapies, Inc. has on average historically risen by 4.9% based on the past 5 years of stock performance.
-
Taysha Gene Therapies, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Taysha Gene Therapies, Inc. Stock Undervalued?The current Taysha Gene Therapies, Inc. [TSHA] share price is $5.49. The Score for TSHA is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
TSHA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Taysha Gene Therapies, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Taysha Gene Therapies, Inc. has on average historically risen by 4.9% based on the past 5 years of stock performance.
Taysha Gene Therapies, Inc. Stock Rating
Buy
60
Taysha Gene Therapies, Inc. (TSHA)
is a Buy
Is Taysha Gene Therapies, Inc. overpriced?
-
Taysha Gene Therapies, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Taysha Gene Therapies, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tayshagtx.com
52-Week Data
52-Week High:
5.95
52-Week Low:
1.05
Prediction Charts
Market Cap:
1.5B
Price in USD:
5.49
Volume:
9M
Beta:
1.03
Technical Analysis
SMA50:
4.77
SMA100:
3.98
SMA200:
3.08
52-Wk Change:
196.76%
Stock Predictions
-
Is Taysha Gene Therapies, Inc. stock public?Yes, Taysha Gene Therapies, Inc. is a publicly traded company.
-
What is the Taysha Gene Therapies, Inc. stock quote today?The Taysha Gene Therapies, Inc. stock price is 5.49 USD today.
-
How to buy Taysha Gene Therapies, Inc. stock online?You can buy Taysha Gene Therapies, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 4.44 | 4.06 | 4.47 | 4.03 |
| Dec-3 | 4.10 | 4.49 | 4.52 | 4.10 |
| Dec-4 | 4.82 | 5.06 | 5.10 | 4.65 |
| Dec-5 | 5.13 | 5.05 | 5.24 | 5.01 |
| Dec-8 | 5.12 | 5.45 | 5.54 | 5.10 |
| Dec-9 | 5.40 | 5.31 | 5.53 | 5.30 |
| Dec-10 | 5.27 | 5.56 | 5.64 | 5.22 |
| Dec-11 | 5.57 | 5.76 | 5.81 | 5.46 |
| Dec-12 | 5.76 | 5.79 | 5.95 | 5.70 |
| Dec-15 | 5.85 | 5.76 | 5.95 | 5.73 |
| Dec-16 | 5.71 | 5.82 | 5.91 | 5.71 |
| Dec-17 | 5.77 | 5.44 | 5.89 | 5.42 |
| Dec-18 | 5.54 | 5.45 | 5.72 | 5.37 |
| Dec-19 | 5.45 | 5.49 | 5.71 | 5.42 |
Taysha Gene Therapies, Inc. Earnings
Taysha Gene Therapies, Inc. Earnings Report: Per Share Taysha Gene Therapies, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Taysha Gene Therapies, Inc. Forecast Revenue Growth
Taysha Gene Therapies, Inc. Stock Analysis: Historical quarterly revenues per share for Taysha Gene Therapies, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.10 per share.
* Taysha Gene Therapies, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.